Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06820606

Comparing Rezum and Urolift

Conditions: Benign Prostatic Hyperplasia

Sex: Male
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Chinese University of Hong Kong

Location: Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong

Summary

This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.

Eligibility Criteria

Inclusion Criteria: * Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml Exclusion Criteria: * History or high suspicion of prostate cancer * Current urinary tract infection * Refractory urinary retention or post-void residual (PVR) ≥250 mL * Intravesical prostatic protrusion (IPP)\>10mm * Prior prostate surgery * Known or suspected allergy to nickel, titanium, or polyester/polypropylene * Urethral stricture, meatal stenosis, bladder neck contracture * Neurogenic bladder and/or sphincter abnormalities

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06820606). StuddyBuddy aggregates publicly available trial information.